OptiBiotix Health (OPTI) Receives Corporate Rating from FinnCap

Share on StockTwits

FinnCap reiterated their corporate rating on shares of OptiBiotix Health (LON:OPTI) in a research note issued to investors on Monday morning.

LON:OPTI opened at GBX 92.50 ($1.21) on Monday. OptiBiotix Health has a 12 month low of GBX 54.30 ($0.71) and a 12 month high of GBX 90 ($1.18).

About OptiBiotix Health

Optibiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.

Featured Article: How to calculate the intrinsic value of a stock

Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply